The shares of this small-cap gained up to 8 percent in the morning session after the company bagged a prestigious purchase order from the Government of Tanzania for Rs 14.91 crore.
With a market capitalization of Rs 2,129.67 crore, the shares of CUPID LTD were trading at Rs 79.74 per share, increasing around 5.31 percent as compared to the previous closing price of Rs 75.72 apiece.
Reason for Rise
The shares of the company have seen positive movement after CUPID LTD bagged a prestigious purchase order from the Medical Stores Department, Government of Tanzania for the supply of male condoms, the order valued at Rs 14.91 crore.
Financial performance
Looking into Cupid’s performance, revenue jumped by 30 percent from Rs 36 crore in Q2FY24 to Rs 47 crore in Q2FY25. During the same duration, net profit climbed by 100 percent from Rs 5 crore to Rs 10 crore.
Expansion Plans
Cupid is in the process of constructing a new plant in Palava, with plans to commence operations by December 2025. The company has already finalized contracts for machinery and is actively working on land development for this facility.
Market Growth
The company aims to enhance its presence in the domestic B2C market, targeting revenue of ₹60 crore by the end of FY25 through an extensive distribution network that plans to reach over 150,000 retail touchpoints. Furthermore, Cupid anticipates achieving ₹125 crore in revenues from this segment by FY26.
Management Guidance:-
Cupid’s management emphasizes ongoing improvements in operational efficiency despite rising costs associated with depreciation and employee expenses. This focus is expected to continue driving profitability as the company expands its product offerings and market reach.
Product Diversification
The introduction of new products such as personal lubricants and hygiene items reflects Cupid’s strategy to diversify its portfolio and cater to evolving consumer needs in both domestic and international markets.
Company snapshot:-
Cupid Limited is an India-based condom manufacturer. The company manufactures and supplies male and female condoms, water-based lubricant jelly, and in vitro diagnostics (IVD) kits. Its production site is at Sinnar, near Nashik, around 200 kilometers east of Mumbai.
Written by:- Abhishek Singh
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses
